₹203.45
+9.65 (+4.98%)
As of 21 Sept 2026, Kilitch Drugs (India) Ltd share price is ₹203.45. The stock opened at ₹203.45 and had closed at ₹193.80 the previous day. Over the last 52 weeks, the stock has recorded a low of ₹121.10 and a high of ₹219.68. In terms of performance, Kilitch Drugs (India) Ltd share price has increased by 23.02% over the past six months and has increased by 9.97% over the last year.
KILITCH Stock Price Chart
Kilitch Drugs (India) Ltd Overview
Market cap₹678 Crs
Volume13,395
Prev. Close₹193.80
Year range₹121.10 - ₹219.68
ISININE729D01010
About KILITCH
Kilitch Drugs (India) is engaged in operation and management of Pharmaceutical Products.
Kilitch Drugs (India) Ltd Historical Performance
1 Month Return18.35%
6 Month Return21.50%
3 Year Return75.91%
3 Month Return6.28%
1 Year Return6.67%
5 Year Return137.88%
Kilitch Drugs (India) Ltd Fundamentals
ROCE(TTM)10.44%
P/E Ratio (TTM)20.75
P/B Ratio2.03
Debt to Equity0.27
ROE9.73%
EPS (TTM)9.34
Dividend Yield0.00%
Book Value95.25
Profit Margin16.72%
Operating Margin15.85%
Kilitch Drugs (India) Ltd Financials
| Indicator | Mar 26 | Mar 25 | Mar 24 | Mar 23 | Mar 22 |
|---|---|---|---|---|---|
| Revenue | 202.42 | 195.31 | 137.79 | 122.38 | 109.72 |
| EBITDA | 46.28 | 44.56 | 26.50 | 21.78 | 15.55 |
| Net Profit | 32.40 | 31.16 | 17.57 | 15.72 | 10.53 |
| EPS | 9.57 | 19.37 | 11.03 | 10.09 | 6.76 |
Kilitch Drugs (India) Ltd Technical Analysis
| Indicator | Value |
|---|---|
| Support 1 (S1) | 189.87 |
| Resistance 1 (R1) | 196.87 |
| Pivot Point | 192.93 |
KILITCH Key Leadership Details
Last Updated: Mar 2026
| Name | Position |
|---|---|
| Mukund P Mehta | Chairman & Managing Director |
| Bhavin M Mehta | E D & Wholetime Directorector |
| Mira Mehta | Managing Director |
Kilitch Drugs (India) Ltd Peer Comparison
| Company | Price | M.Cap (Cr) | P/E (TTM) | ROE (TTM) |
|---|---|---|---|---|
| Sun Pharmaceutical Industries LtdSUNPHARMA | ₹1,869.00+1.73% | ₹4,19,727.66 | 38.32 | 13.74% |
| Divis Laboratories LtdDIVISLAB | ₹9,404.50+0.31% | ₹1,67,235.91 | 67.46 | 15.32% |
| Torrent Pharmaceuticals LtdTORNTPHARM | ₹4,953.00+2.33% | ₹1,46,951.32 | 64.68 | 25.49% |
Disclaimer
The information provided on this page is for informational purposes only and should not be construed as investment advice, recommendation, or solicitation to buy or sell any securities or financial pr...
Frequently Asked Questions
- The share price of Kilitch Drugs (India) Ltd today is ₹203.45 on NSE and ₹203.45 on BSE.
- The 52-week high of Kilitch Drugs (India) Ltd is ₹219.68, while the 52-week low is ₹121.10.
- The current market capitalisation of Kilitch Drugs (India) Ltd is approximately ₹678 crore.
- The P/E (Price-to-Earnings) ratio of Kilitch Drugs (India) Ltd is 22.01. The ratio may vary with changes in the share price and earnings.
- The P/B (Price-to-Book) ratio of Kilitch Drugs (India) Ltd is 2.06. It compares the company’s market value with its book value and can provide an indication of how the market values the company relative to its net assets.
- To buy Kilitch Drugs (India) Ltd shares, you first need to open a demat account before you can place an order. Here's the process:
• Open a demat account online using your PAN, Aadhaar and bank details.
• Add funds to your trading account via UPI or net banking.
• Search for KILITCH on TradeMobi or the Anand Rathi web platform.
• Place your order
• Track your holdings in the portfolio section. - Over the past 3 years, Kilitch Drugs (India) Ltd has delivered a return of approximately 75.91%. This return is based on the change in the share price over the specified period and may differ depending on the measurement date. Past performance does not guarantee future returns.
- The shareholding pattern of Kilitch Drugs (India) Ltd comprises different categories of shareholders. As of Jun 2026, the shareholding is approximately 63.77% promoters, 0.12% FIIs, 0.00% DIIs, and 29.64% public shareholders.
Download TradeMobi App
- Real-Time Market Data
- Advanced Trading Tools
- Expert-Backed Research
